Avant Brands (AVNT) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
14 Apr, 2026Company overview and market presence
Operates four licensed indoor cannabis cultivation facilities with about 180 employees and over $41 million in annual sales.
Recognized as one of Canada's fastest-growing companies, ranked 138th by The Globe & Mail in 2025.
Distributes through domestic recreational, export, domestic B2B, and medical channels, with products available across Canada and in international markets like Israel, Australia, and Germany.
Holds GACP and ICANN-GAP certifications for export, ensuring high regulatory and environmental standards.
Financial performance and highlights
Achieved $8.4 million in Q1 2026 sales and produced 3,006 kg of cannabis.
Generated $0.3 million in net cash flows from operating activities in Q1 2026.
Reported $41.3 million in gross sales and $35.9 million in net sales for fiscal 2025.
Gross margin for 2025 was $7.7 million, with consistent year-over-year sales growth.
Cultivation and production capabilities
Facilities in British Columbia and Ontario with a combined production capacity exceeding 16,000 kg annually.
Employs advanced indoor cultivation, environmental controls, and post-harvest techniques to maximize quality and margins.
Portfolio includes over 75 exclusive cultivars, focusing on unique and rare strains.
Latest events from Avant Brands
- Sixth consecutive positive Adjusted EBITDA and 11% export revenue growth highlight Q2 2025.AVNT
Q2 202523 Apr 2026 - Recreational sales surged 37% while export declines and upgrades weighed on Q1 profit.AVNT
Q1 202614 Apr 2026 - Premium cannabis producer with strong export markets and certified indoor facilities.AVNT
Investor presentation1 Apr 2026 - Gross sales hit $41.3M, recreational revenue up 19%, and net loss down 56% in F2025.AVNT
Q4 20256 Mar 2026 - Revenue and cash flow rose sharply, with domestic wholesale up 307% and EBITDA positive again.AVNT
Q3 202527 Oct 2025 - Record Q3 revenue and export growth highlight Avant's accelerating global cannabis expansion.AVNT
Q3 202413 Jun 2025 - Record Q2 revenue and profitability driven by surging international cannabis sales.AVNT
Q2 202413 Jun 2025 - International sales growth drives revenue gains despite margin compression.AVNT
Q1 20256 Jun 2025 - Record revenue and export growth position Avant Brands for further international expansion.AVNT
Q4 20245 Jun 2025